# Huiying Taifu Investment

> Huiying Taifu Investment is a VC fund in Beijing backing Tea, Consumer and Clinical Trials. See 3 investments, check sizes, portfolio. Updated Sep 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 3
- Last investment: Jan 2019
- Lead investor: 0%
- Last updated: Sep 2026

Huiying Taifu Investment is a VC fund in Beijing focused on Tea and Consumer. Beijing Huiying Taifu Investment Management is an investment Firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Tea | 1 | 33% |
| Consumer | 1 | 33% |
| Clinical Trials | 1 | 33% |
| Consumer Software | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Seed | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Immvira | Immvira was founded in Shenzhen China in May of 2015 by Prof. Bernard Roizman of University of Chicago and Prof. Grace Zhou formerly a Research Associate Professor at University of Chicago, Prof. Thomas Shenk of Princeton University, Prof. Richard Whitley of University of Alabama, Prof. Ralph Weichselbaum of University of Chicago. | $15M | Series A | Jan 31, 2019 |  |
| Tiger Sugar | Tiger Tang is a chain dessert company. Their drinks consist of brown sugar, milk, and tapioca pearls. Tiger Tangs product line includes brown sugar boba thick fresh milk, Tiger frozen thick fresh milk, brown sugar mochi bobo, and mochi bobo replica black tea thick latte. | $21.5M | Series A | Oct 29, 2018 |  |
| Tiger Sugar | Tiger Tang is a chain dessert company. Their drinks consist of brown sugar, milk, and tapioca pearls. Tiger Tangs product line includes brown sugar boba thick fresh milk, Tiger frozen thick fresh milk, brown sugar mochi bobo, and mochi bobo replica black tea thick latte. |  | Seed | May 16, 2018 |  |

3 of 3 investments shown.

## Co-investors
- [BOHE Angel Fund](https://shizune.co/investors/profile/bohe-angel-fund) — VC Fund, 1 deal together
- Hanwei Capital — VC Fund, 1 deal together
- Kangchun Capital — VC Fund, 1 deal together
- [Leaguer Group](https://shizune.co/investors/profile/leaguer-group) — VC Fund, 1 deal together
- [Med-Fine Capital](https://shizune.co/investors/profile/med-fine-capital) — VC Fund, 1 deal together
- Ruishuo Capital — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Huiying Taifu Investment invest in?

Huiying Taifu Investment invests primarily in Tea, Consumer and Clinical Trials startups, most often at Series A and Seed stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Huiying Taifu Investment last invest?

The most recent investment recorded for Huiying Taifu Investment closed in Jan 2019. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co